Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan-Reference-Cited by-同舟云学术

Cost-effectiveness analysis of pegfilgrastim in patients with non-small cell lung cancer receiving ramucirumab plus docetaxel in Japan

Published:2022-05-07 Issue:8 Volume:30 Page:6775-6783
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Kondo Yu^ORCID,Tachi Tomoya,Sakakibara Takayoshi,Kato Jun,Kato Aki,Mizuno Takahito,Miyake Yoshio,Teramachi Hitomi

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-022-07102-6.pdf

Reference40 articles.

1. Smith TJ, Bohlke K, Lyman GH, Carson KR, Crawford J, Cross SJ et al (2015) Recommendations for the use of WBC Growth Factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 33:3199–3212. https://doi.org/10.1200/JCO.2015.62.3488

2. NCCN (2021) NCCN practice guidelines in oncology. Hematopoietic Growth Factors 2021 ver. 4. https://www.nccn.org/professionals/physician_gls/pdf/growthfactors.pdf. Accessed Jan 15 2022

3. Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M et al (2016) Management of febrile neutropaenia: ESMO clinical practice guidelines. Ann Oncol 27:v111–v118. https://doi.org/10.1093/annonc/mdw325

4. Cooper KL, Madan J, Whyte S, Stevenson MD, Akehurst RL (2011) Granulocyte colony-stimulating factors for febrile neutropenia prophylaxis following chemotherapy: systematic review and meta-analysis. BMC Cancer 11:404. https://doi.org/10.1186/1471-2407-11-404

5. Garon EB, Ciuleanu TE, Arrieta O, Prabhash K, Syrigos KN, Goksel T et al (2014) Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial. Lancet 384:665–673. https://doi.org/10.1016/s0140-6736(14)60845-x